Combination strategy could hold promise for ovarian cancer

Source: sciencedaily.com
Gynaecology & Obstetrics

Mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone, report investigators.